Oral candidiasis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
ART was associated with lower oral candidiasis prevalence.
1 finding from 1 review
OR 0.35 [0.19, 0.63]
7 studies
Very low
Recurrent oral ulceration prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in recurrent oral ulceration between CLWH with and without ART (very low certainty).
1 finding from 1 review
OR 1.50 [0.72, 3.13]
Studies not reported
Very low
Oral hairy leukoplakia prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No significant difference in oral hairy leukoplakia between CLWH with and without ART (very low certainty).
1 finding from 1 review
OR 2.75 [0.39, 19.43]
Studies not reported
Very low
Proportion of children with other untreated oral health needs · School children (aged 4 to 15 years), primary and secondary schools in the UK and India
The review found no eligible studies for this question.
1 finding from 1 review
Oral hairy leukoplakia (WHO clinical stage 3) · Children or adolescents
No difference in oral hairy leukoplakia between groups (pooled OR 1.00, 95% CI 0.06 to 16.19); lesion essentially absent in both.
1 finding from 1 review
Failure to achieve complete abortion · women undergoing first trimester abortion
Oral misoprostol probably leads to higher failure to achieve complete abortion compared with vaginal misoprostol (moderate certainty).
2 findings from 1 review
Nausea · women undergoing first trimester abortion
Oral misoprostol may leads to higher nausea compared with vaginal misoprostol (low certainty).
2 findings from 1 review
Women's dissatisfaction with the procedure · women undergoing first trimester abortion
The review found no eligible studies for this question.
2 findings from 1 review
Blood transfusion · women undergoing first trimester abortion
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Oral candidiasis (WHO clinical stage 3) · Children or adolescents
CLWH on ART had markedly higher prevalence of oral candidiasis than healthy controls (pooled OR 16.94, 95% CI 5.06 to 56.70).
1 finding from 1 review
Oral hairy leukoplakia prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
No eligible studies compared oral hairy leukoplakia between different ART regimens.
1 finding from 1 review
Oral health-related quality of life · Children with dental caries
SDF had no significant effect on oral health-related quality of life versus pooled standard-of-care caries treatments (SMD -0.06, 95% CI -0.20 to 0.08; ungraded).
1 finding from 1 review
Oral candidiasis prevalence · Children and adolescents (<18 years) living with HIV (CLWH)
cART was associated with a significantly lower prevalence of oral candidiasis than monotherapy or dual therapy (very low certainty).
1 finding from 1 review
OR 0.22 [0.16, 0.29]
4 studies
Very low
Oral disease prevalence · Children with leukemia in the United Arab Emirates
Oral problems prevalence was 60%.
1 finding from 1 review
Prevalence 60
1 study
GRADE not reported
Plaque/gingivitis visible in at least one oral region · School children aged 11-17 years in Sharjah
Plaque or gingivitis was visible in at least one oral region in 95% of participants.
1 finding from 1 review
Visible plaque and oral-hygiene behavior · Schoolchildren aged 4-6 years in the United Arab Emirates (Dubai)
One pre-post study of a school-based supervised tooth-brushing program found visible plaque fell from 76.8% to 36.7% with positive behavior change (narrative synthesis; not GRADE-rated).
1 finding from 1 review
Al Mashhadani evaluated a 3-month school-based daily tooth-brushing program (1,500 students aged 4-6 in 7 private and governmental schools). The presence of visible plaque decreased from 76.8% to 36.7%…
1 study · 1500 participants
GRADE not reported
Poor (inadequate) oral hygiene (prevalence) · Autistic children and young adults in Dubai
Poor oral hygiene prevalence was 59%.
1 finding from 1 review
Prevalence 59
1 study
GRADE not reported
Complete response · patients with cutaneous disease in systemic lupus erythematosus
Oral chloroquine showed no clear difference in primary outcome: complete clinical response compared with placebo (low certainty).
1 finding from 1 review
Primary outcome: partial clinical response · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review
Secondary outcome: clinical flare · patients with cutaneous disease in systemic lupus erythematosus
1 finding from 1 review